Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-412-2 | CAS number: 59-02-9
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Feb - Mar 1986
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Reliable guideline study with limited information about test item.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The LLNA method was not available at the time this test was performed.
- Species:
- guinea pig
- Strain:
- other: Pirbright white
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Winkelmann, Borchen (Germany):
- Weight at study initiation: 327 - 514 g
- Housing: in Makrolon cages (5 animals per cage)
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C):
- Humidity (%):
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light):
IN-LIFE DATES: From: 17.02.1986 To: 14.03.1986 - Route:
- intradermal and epicutaneous
- Vehicle:
- other: vaseline
- Concentration / amount:
- Intradermal induction: 0.5 % in soybean oil
epicutaneous induction: 5 % in vaseline
challenge: 1 % in vaseline - Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- Intradermal induction: 0.5 % in soybean oil
epicutaneous induction: 5 % in vaseline
challenge: 1 % in vaseline - No. of animals per dose:
- 20
- Details on study design:
- RANGE FINDING TESTS: 3 tests were done with 5 guinea pigs each
- group A: intracutaneous application: 0.1, 0.5, 1.0, 2.0 % (vehicle: soybean oil)
- group B: dermal induction: 5, 10 % (vehicle: vaseline)
- goup C: intracutaneous injection of Freund's adjuvans (0.1 ml), in the 3rd week: dermal induction: 0.2 g of a 2.5 and 5% solution
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures:
- 1st induction: 6 intradermal injections (Freund'S Adjuvans, 0.5 % test item)
- 2nd induction: one week after intradermal induction, dermal inducation (5 % in vaseline)
- Exposure period: 48 h
- Test groups: 20
- Control group: 20
B. CHALLENGE EXPOSURE
- Day(s) of challenge: 14 days after last induction
- Exposure period: 24 h
- Concentrations: 1% in vaseline
- Evaluation (hr after challenge): 24, 48 h - Challenge controls:
- no data
- Positive control substance(s):
- no
- Positive control results:
- no data
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1 % in vaseline
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 1 % in vaseline. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1 % in vaseline
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1 % in vaseline. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: none.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- According to these test results the test item can be classified as "no skin sensitizer" in the Magnusson-Kligman test on guinea pigs.
- Executive summary:
The test item was tested for its sensitization potential in guinea pigs, using the method of B. Magnusson and A. M. Kligman, J. Invest. Dermatol. 52, 268 -276 (1969).
First the minimum irritant concentration for the induction application (intracutaneous and epidermal) and the maximum non irritant concentration for the challenge application were estimated in separate tests.
For the main test 20 female test animals and 20 controls, Pirbright white strain, were used. The initial average body weight for the test group animals was 327 g, that one of the control animals was 333 g. For the dilution of the test concentration of the intracutaneous test soybean oil and for the epicutaneous application paraffinum album were used. The Vitamin E-product was applied in the induction phase in 0.5 % (intracutaneous application) respectively in 5 per cent concentration (epidermal application). The challenge concentration was 1 per cent.
24 and 48 hours after the removing of the patches of the challenge application neither the test nor the control animals showed any skin reactions on the treated skin areas.
According to these test results the test item can be classified as "no skin sensitizer" in the Magnusson-Kligman test on guinea pigs.
Reference
No changes in bodyweight gain were seen. No mortality occurred. No skin reactions were noted after challenge.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The evaluation of the skin sensitizing potential of D-alpha-Tocopherol is based on two in-vivo studies with the test item and a reliable publication.
The skin sensitizing potential of the test item was assessed using the Guinea pig maximization test. The assays are done according to the OECD guideline 406.
Key Study:
For the GPMT 20 female test animals and 20 controls, Pirbright white strain, were used. For the dilution of the test concentration of the intracutaneous test soybean oil and for the epicutaneous application paraffinum album were used.
24 and 48 hours after the removing of the patches of the challenge application neither the test nor the control animals showed any skin reactions on the treated skin areas.
According to these test results the test item can be classified as "no skin sensitizer" in the Magnusson-Kligman test on guinea pigs.
Supporting Study:
The first supporting study was done according to the key study. 24 and 48 hours after the removing of the patches of the challenge application neither the test nor the control animals showed any skin reactions on the treated skin areas.
According to these test results the test item can be classified as "no skin sensitizer" in the Magnusson-Kligman test on guinea pigs.
Supporting Study:
The sensitizing properties of D-alpha-Tocopherol (Purity 87%) was evaluated in the guinea pig maximization test.
20 guinea pigs were used for the test group and 19 guinea pigs were used for the control group.
Sensitization rate was 0/20 and 0/19 in the test and control group, respectively. The test substance was not a sensitizer under the conditions of this study.
The information available on the skin sensitizing potential of the test item show no need for a classification of the test item concerning skin sensitization.
Migrated from Short description of key information:
Skin sensitisation:
Key: not sensitising (GPMT)
Supporting study: not sensitising (GPMT)
Supporting study: not sensitising (GPMT, publication)
Justification for selection of skin sensitisation endpoint:
Reliable guideline study which is the basis for classification.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The available data on skin sensitization does not meet the criteria for classification according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
